+ + HIGH LOW +

H.R. 2820: Stem Cell Therapeutic and Research Reauthorization Act of 2015

CBO Score

$220 million

Date of Report

Fri December 4th, 2015

CBO Report Details

Legislation Details

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

114th Congress
Sponsor: Rep. Christopher Smith — R — NJ

Introduced 06/18/15
Passed House: 12/16/15
Passed Senate: 12/16/15
Latest Action: 12/18/15

This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.) The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program. (Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised. HHS must determine whether to include peripheral blood stem cells ...

View on GovTrack.us

Lost your Password?

Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.

×